Wave Life Sciences Ltd (WVE) financials
Wave Life Sciences revenue and earnings by year
Wave Life Sciences's revenue was $42.7 million in the fiscal year to December 31, 2025, down 60.5% from the year before. Net income was -$204 million, -478.3% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 50.3% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43 | 108 | 113 | 4 | 41 | 20 | 16 | 14 | 4 | 1 |
| Revenue growth | -60.5% | -4.4% | 3005.1% | -91.1% | 104.0% | 25.6% | 10.9% | 270.3% | 256.5% | — |
| Operating income | -215 | -110 | -68 | -163 | -127 | -153 | -208 | -160 | -102 | -56 |
| Operating margin | -504.1% | -101.9% | -60.0% | -4459.3% | -310.1% | -763.9% | -1303.4% | -1106.7% | -2630.1% | -5102.6% |
| Net income | -204 | -97 | -58 | -162 | -122 | -150 | -194 | -147 | -102 | -56 |
| Net margin | -478.3% | -89.6% | -50.8% | -4434.7% | -298.4% | -746.7% | -1211.5% | -1017.4% | -2619.6% | -5097.1% |
| Diluted EPS | -$1.21 | -$0.70 | -$0.54 | -$2.05 | — | — | — | — | — | — |
| Free cash flow | -188 | -152 | -21 | -129 | -90 | -117 | -192 | -33 | -103 | -37 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open WVE in Markets.
See also: WVE returns
No forecast, no recommendation. This page describes Wave Life Sciences Ltd from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.